Skip to main content
. 2021 Sep 24;10(10):2526. doi: 10.3390/cells10102526
API active pharmaceutical ingredient
ATCC American type culture collection
ATMP advanced therapy medicinal product
bp base pairs
CAM chorioallantoic membrane
CHUV Centre hospitalier universitaire Vaudois
DMEM Dulbecco’s modified Eagle medium
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
EDQM European Directorate for the Quality of Medicines & Healthcare
EOPCB end of production cell bank
EP European Pharmacopoeia
EU European Union
FBS fetal bovine serum
FDA US Food and Drug Administration
FPC fibroblast progenitor cell
GMP good manufacturing practices
HIV human immunodeficiency virus
hPL human platelet lysate
ICH International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use
iPSC induced pluripotent stem cells
MCB master cell bank
MRC Medical Research Council
MSC mesenchymal stem cells
NA not applicable
NIBSC National Institute for Biological Standards and Control
NIH National Institutes of Health
PBB Progenitor Biological Bandage
PCB parental cell bank
PDL population doubling level
PL passage level
SV40 simian virus 40
US United States of America
WCB working cell bank
WHO World Health Organization
WI Wistar Institute